Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A multicenter, double-blind, parallel group, placebo-controlled clinical study to examine the safety and efficacy of T-Clair SPHP700-3 in the management of mild to moderate dry eye in adults.

Villani E, Laganovska G, Viola F, Pirondini C, Baumane K, Radecka L, Ratiglia R.

Cornea. 2011 Mar;30(3):265-8. doi: 10.1097/ICO.0b013e3181e9aab8.

PMID:
21099417
2.

Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).

Vogel R, Crockett RS, Oden N, Laliberte TW, Molina L; Sodium Hyaluronate Ophthalmic Solution Study Group.

Am J Ophthalmol. 2010 Apr;149(4):594-601. doi: 10.1016/j.ajo.2009.09.023.

PMID:
20346777
3.

Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.

Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N; Rebamipide Ophthalmic Suspension Phase II Study Group.

Ophthalmology. 2012 Dec;119(12):2471-8. doi: 10.1016/j.ophtha.2012.06.052. Epub 2012 Sep 23.

PMID:
23009892
4.

Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.

Johnson ME, Murphy PJ, Boulton M.

Optom Vis Sci. 2008 Aug;85(8):750-7. doi: 10.1097/OPX.0b013e318182476c.

PMID:
18677239
5.

Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.

Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K; Diquafosol Ophthalmic Solution Phase 2 Study Group.

Ophthalmology. 2012 Oct;119(10):1954-60. doi: 10.1016/j.ophtha.2012.04.010. Epub 2012 Jun 26.

PMID:
22739038
6.

Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study.

Amrane M, Creuzot-Garcher C, Robert PY, Ismail D, Garrigue JS, Pisella PJ, Baudouin C.

J Fr Ophtalmol. 2014 Oct;37(8):589-98. doi: 10.1016/j.jfo.2014.05.001. Epub 2014 Aug 13.

7.
8.

Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.

Tauber J, Davitt WF, Bokosky JE, Nichols KK, Yerxa BR, Schaberg AE, LaVange LM, Mills-Wilson MC, Kellerman DJ.

Cornea. 2004 Nov;23(8):784-92. Erratum in: Cornea. 2007 May;26(4):514.

PMID:
15502479
9.

Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).

Tawfik HA.

Am J Ophthalmol. 2010 Nov;150(5):757; author reply 757. doi: 10.1016/j.ajo.2010.08.005. No abstract available.

PMID:
21036218
10.
11.

Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease.

Lee JH, Ahn HS, Kim EK, Kim TI.

Cornea. 2011 Feb;30(2):175-9. doi: 10.1097/ICO.0b013e3181e9adcc.

PMID:
21045674
12.

Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.

Matsuo T.

Jpn J Ophthalmol. 2004 Jul-Aug;48(4):321-7.

PMID:
15295655
13.

Clinical performance of a mid-viscosity artificial tear for dry eye treatment.

Simmons PA, Vehige JG.

Cornea. 2007 Apr;26(3):294-302.

PMID:
17413956
14.

Isolation of the ocular surface to treat dysfunctional tear syndrome associated with computer use.

Yee RW, Sperling HG, Kattek A, Paukert MT, Dawson K, Garcia M, Hilsenbeck S.

Ocul Surf. 2007 Oct;5(4):308-15.

PMID:
17938840
15.

Tolerability and safety of two new preservative-free tear film substitutes.

Dinslage S, Stoffel W, Diestelhorst M, Krieglstein GK.

Cornea. 2002 May;21(4):352-5.

PMID:
11973381
16.

Choice of artificial tear formulation for patients with dry eye: where do we start?

Tong L, Petznick A, Lee S, Tan J.

Cornea. 2012 Nov;31 Suppl 1:S32-6. doi: 10.1097/ICO.0b013e318269cb99. Review.

PMID:
23038032
17.

[Evaluation of NAAGA efficacy in dry eye syndrome].

Brignole-Baudouin F, Robert PY, Creuzot-Garcher C, Olmiere C, Delval L, Baudouin C.

J Fr Ophtalmol. 2009 Nov;32(9):613-20. doi: 10.1016/j.jfo.2009.09.006. Epub 2009 Oct 24. French.

18.

Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye.

Johnson ME, Murphy PJ, Boulton M.

Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):109-12. Epub 2005 Jun 28.

PMID:
15983814
19.

Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients.

Papa V, Aragona P, Russo S, Di Bella A, Russo P, Milazzo G.

Ophthalmologica. 2001 Mar-Apr;215(2):124-7.

PMID:
11244343
20.

Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.

Brzheskiy VV, Efimova EL, Vorontsova TN, Alekseev VN, Gusarevich OG, Shaidurova KN, Ryabtseva AA, Andryukhina OM, Kamenskikh TG, Sumarokova ES, Miljudin ES, Egorov EA, Lebedev OI, Surov AV, Korol AR, Nasinnyk IO, Bezditko PA, Muzhychuk OP, Vygodin VA, Yani EV, Savchenko AY, Karger EM, Fedorkin ON, Mironov AN, Ostapenko V, Popeko NA, Skulachev VP, Skulachev MV.

Adv Ther. 2015 Dec;32(12):1263-79. doi: 10.1007/s12325-015-0273-6. Epub 2015 Dec 11.

Items per page

Supplemental Content

Write to the Help Desk